People channel feed

Amid scruti­ny of ex­ec stock sales, SEC chair­man echoes calls for 'cool­ing-off pe­ri­od' in trad­ing plans

5 years ago
FDA+

Phar­ma lob­by­ist and long­time Biden loy­al­ist Steve Ric­chet­ti joins the in­ner cir­cle head­ed to the White House as drug pric­ing re­mains a hot top­ic

5 years ago
Pharma

Retrophin no more: Shkre­li's lega­cy dis­ap­pears as for­mer com­pa­ny be­comes Tra­vere Ther­a­peu­tics

5 years ago
Pharma

Fa­heem Has­nain is go­ing back to run­ning a biotech start­up. And he has his work cut out for him

5 years ago
R&D

A phar­ma R&D chief jumps to a bud­ding new start­up fac­to­ry — and this time he’s found 'some­thing com­plete­ly dif­fer­ent’

5 years ago
Startups

As the cur­tain clos­es on the Trump pres­i­den­cy, biotech wres­tles with its fu­ture in a di­vid­ed Amer­i­ca

5 years ago
In Focus

As Pfiz­er's stock surged Mon­day, Al­bert Bourla net­ted $5.6M in stock sales

5 years ago
Coronavirus

Vivek Ra­maswamy eyes an I/O vant with up to $2B li­cens­ing deal

5 years ago
Deals

'We're not a van­t': Ax­o­vant seeks to for­get the past as the com­pa­ny re­brands to Sio Gene Ther­a­pies

5 years ago
Cell/Gene Tx

Leg­end Biotech has a new chair­woman and per­ma­nent CEO. But where is Frank Zhang?

5 years ago
Cell/Gene Tx

Two years af­ter a re­buffed ac­tivist at­tack, Alex Den­ner fi­nal­ly gets his seat on Iron­wood's board

5 years ago

Pre­vail and Alec­tor both claim vic­to­ry in ar­bi­tra­tion over sci­en­tist-CEO, telling di­ver­gent tales of con­fi­den­tial hear­ings

5 years ago
Pharma

San­thera ax­es half its em­ploy­ees and sees CMO de­part af­ter PhI­II DMD fail

5 years ago
R&D

Sean Bo­hen just wrote the hand­book on how to make a quick for­tune in biotech

5 years ago
Financing
Bioregnum

Bel­licum slash­es 79% of staffers af­ter ear­ly da­ta quash hope around next-gen CAR-T

5 years ago
Cell/Gene Tx

George Golumbes­ki and Fa­heem Has­nain team up with Ver­tex Ven­tures HC in man­ag­ing $320M of biotech cash

5 years ago
Financing

Bay­er fol­lows R&D deal spree by raid­ing Roche's can­cer group for its new re­search chief

5 years ago
R&D

Af­ter falling be­hind the lead­ers, dissed by some ex­perts, biotech show­man Patrick Soon-Sh­iong fi­nal­ly gets his Covid-19 vac­cine ready for a tri­al. But can it live up to the hype?

5 years ago
Coronavirus
In Focus

Patrick Soon-Sh­iong steps down as CEO of Nan­tK­west, a linch­pin of his 'Cancer Moon­shot'

5 years ago

In­di­v­ior's Shaun Thax­ter heads to prison, join­ing In­sys' John Kapoor among jailed opi­oid ex­ecs

5 years ago
Pharma

Mas­ter deal­mak­er David Hung re­tools a SPAC sedan in­to a fi­nanc­ing mus­cle ve­hi­cle that leaves his can­cer start­up with $850M and a place on Wall Street

5 years ago
Deals

Roche finds a home for a new, $500M man­u­fac­tur­ing lo­gis­tics hub, promis­ing 500 jobs

5 years ago
Outsourcing
Pharma

The prospect of an Oc­to­ber OK large­ly closed, Pfiz­er's Al­bert Bourla promis­es not to sub­mit for EUA un­til No­vem­ber

5 years ago
Pharma
Coronavirus

No­var­tis vet Dan­ny Bar-Zo­har leaps back in­to R&D, tak­ing over the de­vel­op­ment team at Mer­ck KGaA as Lu­ciano Ros­set­ti steps out

5 years ago
First page Previous page 64656667686970 Next page Last page
A service from the Financial Times